KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to -$127.0 million.

  • Thermo Fisher Scientific's Deferred Taxes rose 6825.0% to -$127.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 54023.67%. This contributed to the annual value of $1.2 billion for FY2024, which is 700.0% down from last year.
  • Latest data reveals that Thermo Fisher Scientific reported Deferred Taxes of -$127.0 million as of Q3 2025, which was up 6825.0% from -$880.0 million recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Deferred Taxes ranged from a high of $2.2 billion in Q4 2024 and a low of -$880.0 million during Q2 2025
  • For the 5-year period, Thermo Fisher Scientific's Deferred Taxes averaged around $180.2 million, with its median value being $192.0 million (2021).
  • As far as peak fluctuations go, Thermo Fisher Scientific's Deferred Taxes skyrocketed by 151250.0% in 2022, and later plummeted by 57252.75% in 2024.
  • Quarter analysis of 5 years shows Thermo Fisher Scientific's Deferred Taxes stood at $192.0 million in 2021, then plummeted by 30.73% to $133.0 million in 2022, then skyrocketed by 403.01% to $669.0 million in 2023, then surged by 231.24% to $2.2 billion in 2024, then tumbled by 105.73% to -$127.0 million in 2025.
  • Its Deferred Taxes was -$127.0 million in Q3 2025, compared to -$880.0 million in Q2 2025 and $279.0 million in Q1 2025.